Back to ERNA

Eterna Therapeutics Inc. 8-K

Accession 0001140361-22-044329

Filing information

CIK
0000748592
Report date
2022-12-02
Filing date
2022-12-05
Form
8-K
Primary document
brhc10045002_8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.